VarCov Co’s Novavax NVAX Stock Holding History

VarCov Co’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$277K	Sell	29,403 -2,554	-8%	-$22.9K	0.11%	288
2026 Q1	$260K	Sell	31,957 -7,107	-18%	-$64.4K	0.1%	315
2025 Q4	$263K	Buy	+39,064	New	+$294K	0.1%	325

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

VarCov Co's NVAX Position: Q2 2026 in Review

VarCov Co reduced its Novavax (NVAX) stake by 8% in Q2 2026, selling an estimated $22.9K and leaving 29,403 shares worth $277K. The position accounts for 0.11% of the portfolio, ranked #288.

VarCov Co first reported a position in NVAX in Q4 2025 and has held it in 3 quarters since. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

VarCov Co held 29,403 shares of Novavax worth $277K as of Q2 2026.
VarCov Co sold 2,554 Novavax shares in Q2 2026, an estimated $22.9K.
Novavax made up 0.11% of VarCov Co's portfolio in Q2 2026, its #288 holding.
VarCov Co first reported a position in Novavax in Q4 2025 and has held it in 3 quarters since.
264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.